Volume 10; Issue 2

Expert Opinion on Drug Safety

Volume 10; Issue 2

1

Capecitabine and hand–foot syndrome

Saif, Muhammad Wasif

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 387 KB

english, 2011

2

Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity

Linares, Victoria, Alonso, Virginia, Domingo, José L

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 429 KB

english, 2011

3

Pemetrexed in advanced non-small cell lung cancer

Gridelli, Cesare, Maione, Paolo, Rossi, Antonio, Bareschino, Maria Anna, Schettino, Clorinda, Sacco, Paola Claudia, Zeppa, Rosario

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 214 KB

english, 2011

4

Mirabegron: a safety review

Tyagi, Pradeep, Tyagi, Vikas, Chancellor, Michael

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 267 KB

english, 2011

5

Oral hypoglycemic agents for gestational diabetes mellitus?

Maymone, Ana Cristina, Baillargeon, Jean-Patrice, Ménard, Julie, Ardilouze, Jean-Luc

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 371 KB

english, 2011

6

The role and efficacy of denosumab in the treatment of osteoporosis: an update

Charopoulos, Ioannis, Orme, Steve, Giannoudis, Peter V

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 276 KB

english, 2011

7

Safety of micafungin in infants: insights into optimal dosing

Ascher, Simon, Smith, Phillip Brian, Benjamin, Daniel K

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 186 KB

english, 2011

8

Efalizumab

Talamonti, Marina, Spallone, Giulia, Di Stefani, Alessandro, Costanzo, Antonio, Chimenti, Sergio

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 352 KB

english, 2011

9

A drug safety evaluation of valsartan

Fogari, Roberto, Zoppi, Annalisa

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 322 KB

english, 2011

10

Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients

Scholze, Jürgen, Schaefer, Angie, Kreutz, Reinhold

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 411 KB

english, 2011

11

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

Littlewood, James M, Connett, Gary J, Sander-Struckmeier, Suntje, Henniges, Friederike

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 362 KB

english, 2011

12

Influences of bone and mineral metabolism in epilepsy

Hamed, Sherifa A

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 386 KB

english, 2011

13

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

Cornely, Oliver A, Pappas, Peter G, Young, Jo-Anne H, Maddison, Philip, Ullmann, Andrew J

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 464 KB

english, 2011

14

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

Saad, Amr A, Hyrich, Kimme L, Ashcroft, Darren M

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 414 KB

english, 2011

15

Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes

Avitabile, Nicholas, Banka, Ajaz, Fonseca, Vivian A

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 436 KB

english, 2011

16

Erratum

Journal:

Expert Opinion on Drug Safety

Year:

2011

Language:

english

File:

PDF, 174 KB

english, 2011